Skip to main content
Top
Published in: Virology Journal 1/2015

Open Access 01-12-2015 | Research

Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markers

Authors: Maria-Cristina Arcangeletti, Rosita Vasile Simone, Isabella Rodighiero, Flora De Conto, Maria-Cristina Medici, Davide Martorana, Carlo Chezzi, Adriana Calderaro

Published in: Virology Journal | Issue 1/2015

Login to get access

Abstract

Background

Human cytomegalovirus (HCMV) is still considered to be the main viral cause of birth defects and long-term neurological and sensory sequelae following congenital infection.
Several Authors sustain a key role of HCMV envelope glycoproteins, such as gB, gN and gO - mainly involved in cell targeting, viral penetration and spread - as putative virulence factors. The genes coding for these glycoproteins possess hypervariable regions, resulting in a number of genetic variants in circulating clinical strains. Considering that the genetic polymorphisms underlying the specific differences between gB, gN and gO genotypes can influence the ability of HCMV to preferentially target specific host cells, it is very likely that they play an important role in defining HCMV infection outcome.
In the present study, we analysed HCMV gB, gN and gO gene polymorphisms in viral strains isolated from paediatric patients with congenital or post-natal infection, to investigate whether specific genetic variants may be associated with congenital infection.

Methods

The restriction fragment polymorphisms of genes coding for HCMV gB (UL55), gN (UL73) and gO (UL74) were investigated by analysing viral DNA extracted from 40 urine samples of as many paediatric patients with congenital or post-natal HCMV infection. Randomly selected samples were subjected to DNA sequencing and phylogenetic analysis. Statistical analysis was performed using Fisher’s exact test to assess the significance of single and combined glycoprotein genotypes frequency distribution. Statistical significance was considered at a P <0.05.

Results

While gB genomic variants were quite homogeneously represented in both paediatric groups, the gN4 genotype significantly prevailed in congenitally infected children (89.5 %) vs post-natally infected children (47.6 %), with a predominance of the gN4c variant (47.4 %). A similar trend was observed for gO3 (52.6 % vs 19 %).
Concerning genotypes association, a statistically significant (P = 0.037) gN4-gO3 combination was found specifically in the congenitally infected group.

Conclusions

The results indicate that the gN4 (mostly the gN4c variant) and gO3 combined genotypes could provide useful markers of congenital infection and represent suitable candidate molecules for prophylactic vaccine preparations.
Literature
1.
go back to reference Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990;12 Suppl 7:701–10.CrossRef Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990;12 Suppl 7:701–10.CrossRef
2.
go back to reference Valla F, Lévêque N, Escuret V, Galambrun C, Mialou V, Bleyzac N, et al. Human cytomegalovirus (HCMV) laryngitis: atypical HCMV disease presentation in haematopoietic stem cell transplantation. J Med Microbiol. 2008;57:1434–5.CrossRefPubMed Valla F, Lévêque N, Escuret V, Galambrun C, Mialou V, Bleyzac N, et al. Human cytomegalovirus (HCMV) laryngitis: atypical HCMV disease presentation in haematopoietic stem cell transplantation. J Med Microbiol. 2008;57:1434–5.CrossRefPubMed
3.
go back to reference Schoenfisch AL, Dollard SC, Amin M, Gardner LI, Klein RS, Mayer K, et al. Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol. 2011;60:768–74.CrossRefPubMed Schoenfisch AL, Dollard SC, Amin M, Gardner LI, Klein RS, Mayer K, et al. Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol. 2011;60:768–74.CrossRefPubMed
4.
go back to reference Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv. 2002;57:245–56.CrossRefPubMed Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv. 2002;57:245–56.CrossRefPubMed
6.
go back to reference Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63.CrossRefPubMed Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63.CrossRefPubMed
7.
go back to reference Nijman J, Mandemaker FS, Verboon-Maciolek MA, Aitken SC, van Loon AM, et al. Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection. PLoS One. 2014;9:e108018.PubMedCentralCrossRefPubMed Nijman J, Mandemaker FS, Verboon-Maciolek MA, Aitken SC, van Loon AM, et al. Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection. PLoS One. 2014;9:e108018.PubMedCentralCrossRefPubMed
9.
go back to reference Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis. 2004;39:233–9.CrossRefPubMed Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis. 2004;39:233–9.CrossRefPubMed
10.
go back to reference Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, et al. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis. 2006;194:464–73.CrossRefPubMed Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, et al. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis. 2006;194:464–73.CrossRefPubMed
11.
go back to reference Yu ZS, Zou CC, Zheng JY, Zhao ZY. Cytomegalovirus gB genotype and clinical features in Chinese infants with congenital infections. Intervirology. 2006;49:281–5.CrossRefPubMed Yu ZS, Zou CC, Zheng JY, Zhao ZY. Cytomegalovirus gB genotype and clinical features in Chinese infants with congenital infections. Intervirology. 2006;49:281–5.CrossRefPubMed
12.
go back to reference Jin H, Wang X, Li S. Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology. 2007;50:219–23.CrossRefPubMed Jin H, Wang X, Li S. Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology. 2007;50:219–23.CrossRefPubMed
13.
go back to reference Paradowska E, Studzińska M, Suski P, Kasztelewicz B, Wiśniewska-Ligier M, Zawilińska B, et al. Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally. J Med Virol. 2015;87:1737–48.CrossRefPubMed Paradowska E, Studzińska M, Suski P, Kasztelewicz B, Wiśniewska-Ligier M, Zawilińska B, et al. Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally. J Med Virol. 2015;87:1737–48.CrossRefPubMed
14.
go back to reference Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis. 1991;163:1229–34.CrossRefPubMed Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis. 1991;163:1229–34.CrossRefPubMed
15.
go back to reference Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis. 2004;39:155–61.CrossRefPubMed Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis. 2004;39:155–61.CrossRefPubMed
16.
go back to reference Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol. 2002;76:10841–48.PubMedCentralCrossRefPubMed Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol. 2002;76:10841–48.PubMedCentralCrossRefPubMed
17.
go back to reference Pignatelli S, Lazzarotto T, Gatto MR, Dal Monte P, Landini MP, Faldella G, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis. 2010;51:33–41.CrossRefPubMed Pignatelli S, Lazzarotto T, Gatto MR, Dal Monte P, Landini MP, Faldella G, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis. 2010;51:33–41.CrossRefPubMed
18.
go back to reference Paradowska E, Jabłońska A, Studzińska M, Suski P, Kasztelewicz B, Zawilińska B, et al. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants. J Clin Virol. 2013;58:2715.CrossRef Paradowska E, Jabłońska A, Studzińska M, Suski P, Kasztelewicz B, Zawilińska B, et al. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants. J Clin Virol. 2013;58:2715.CrossRef
19.
go back to reference Mattick C, Dewin D, Polley S, Sevilla-Reyes E, Pignatelli S, Rawlinson W, et al. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology. 2004;318:582–97.CrossRefPubMed Mattick C, Dewin D, Polley S, Sevilla-Reyes E, Pignatelli S, Rawlinson W, et al. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology. 2004;318:582–97.CrossRefPubMed
20.
go back to reference Kropff B, Burkhardt C, Schott J, Nentwich J, Fisch T, Britt W, et al. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies. PLoS Pathog. 2012;8:e1002999.PubMedCentralCrossRefPubMed Kropff B, Burkhardt C, Schott J, Nentwich J, Fisch T, Britt W, et al. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies. PLoS Pathog. 2012;8:e1002999.PubMedCentralCrossRefPubMed
21.
go back to reference Paterson DA, Dyer AP, Milne RS, Sevilla-Reyes E, Gompels UA. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology. 2002;293:281–94.CrossRefPubMed Paterson DA, Dyer AP, Milne RS, Sevilla-Reyes E, Gompels UA. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology. 2002;293:281–94.CrossRefPubMed
22.
go back to reference Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol. 2003;84:647–55.CrossRefPubMed Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol. 2003;84:647–55.CrossRefPubMed
23.
go back to reference Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol. 2004;14:383–410.CrossRefPubMed Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol. 2004;14:383–410.CrossRefPubMed
24.
go back to reference Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA. CIGNIS study group High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology. 2008;382:28–36.CrossRefPubMed Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA. CIGNIS study group High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology. 2008;382:28–36.CrossRefPubMed
25.
go back to reference Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22:99–126.PubMedCentralCrossRefPubMed Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22:99–126.PubMedCentralCrossRefPubMed
26.
go back to reference Paixão P, Almeida S, Videira PA, Ligeiro D, Marques T. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools. Eur J Pediatr. 2012;17:125–9.CrossRef Paixão P, Almeida S, Videira PA, Ligeiro D, Marques T. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools. Eur J Pediatr. 2012;17:125–9.CrossRef
27.
go back to reference Conboy TJ, Pass RF, Stagno S, Alford CA, Myers GJ, Britt WJ, et al. Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 1987;111:343–8.CrossRefPubMed Conboy TJ, Pass RF, Stagno S, Alford CA, Myers GJ, Britt WJ, et al. Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 1987;111:343–8.CrossRefPubMed
28.
go back to reference Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57 Suppl 4:178–81.CrossRef Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57 Suppl 4:178–81.CrossRef
30.
go back to reference Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, et al. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis. 2002;186:114–7.CrossRefPubMed Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, et al. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis. 2002;186:114–7.CrossRefPubMed
31.
go back to reference Goossens VJ, Wolffs PF, van Loo IH, Bruggeman CA, Verbon A. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands. AIDS. 2009;23:1425–9.CrossRefPubMed Goossens VJ, Wolffs PF, van Loo IH, Bruggeman CA, Verbon A. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands. AIDS. 2009;23:1425–9.CrossRefPubMed
32.
go back to reference Woo PC, Lo CY, Lo SK, Siau H, Peiris JS, Wong SS, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol. 1997;4:515–8.PubMedCentralPubMed Woo PC, Lo CY, Lo SK, Siau H, Peiris JS, Wong SS, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol. 1997;4:515–8.PubMedCentralPubMed
33.
go back to reference Bale Jr JF, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis. 2000;182:933–6.CrossRefPubMed Bale Jr JF, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis. 2000;182:933–6.CrossRefPubMed
34.
go back to reference Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol. 2000;61:481–7.CrossRefPubMed Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol. 2000;61:481–7.CrossRefPubMed
35.
go back to reference Barbi M, Binda S, Caroppo S, Primache V, Didò P, Guidotti P, et al. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J Clin Virol. 2001;121:75–9.CrossRef Barbi M, Binda S, Caroppo S, Primache V, Didò P, Guidotti P, et al. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J Clin Virol. 2001;121:75–9.CrossRef
36.
go back to reference Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM, Miranda EC, et al. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect Dis. 2013;13:310.PubMedCentralCrossRefPubMed Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM, Miranda EC, et al. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect Dis. 2013;13:310.PubMedCentralCrossRefPubMed
37.
go back to reference Lukacsi A, Tarodi B, Endreffy E, Babinszki A, Pal A, Pusztai R. Human cytomegalovirus gB genotypes 1 is dominant in congenital infections in south Hungary. J Med Virol. 2001;65:537–42.CrossRefPubMed Lukacsi A, Tarodi B, Endreffy E, Babinszki A, Pal A, Pusztai R. Human cytomegalovirus gB genotypes 1 is dominant in congenital infections in south Hungary. J Med Virol. 2001;65:537–42.CrossRefPubMed
38.
go back to reference Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M, et al. Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants. J Gen Virol. 2008;89:2275–9.CrossRefPubMed Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M, et al. Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants. J Gen Virol. 2008;89:2275–9.CrossRefPubMed
39.
go back to reference Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991;13:315–29.CrossRefPubMed Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991;13:315–29.CrossRefPubMed
40.
go back to reference Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006;35:226–31.CrossRefPubMed Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006;35:226–31.CrossRefPubMed
41.
go back to reference Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J Women Health (Larchmt). 2006;15:224–9.CrossRef Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J Women Health (Larchmt). 2006;15:224–9.CrossRef
42.
go back to reference Pati SK, Novak Z, Purser M, Arora N, Mach M, Britt W, et al. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Clin Vaccine Immunol. 2012;19:909–13.PubMedCentralCrossRefPubMed Pati SK, Novak Z, Purser M, Arora N, Mach M, Britt W, et al. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Clin Vaccine Immunol. 2012;19:909–13.PubMedCentralCrossRefPubMed
43.
go back to reference Görzer I, Kerschner H, Jaksch P, Bauer C, Seebacher G, Klepetko W, et al. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol. 2008;80:1405–14.CrossRefPubMed Görzer I, Kerschner H, Jaksch P, Bauer C, Seebacher G, Klepetko W, et al. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol. 2008;80:1405–14.CrossRefPubMed
44.
go back to reference Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, Danthuluri VR, et al. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis. 2011;204:1003–7.PubMedCentralCrossRefPubMed Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, Danthuluri VR, et al. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis. 2011;204:1003–7.PubMedCentralCrossRefPubMed
45.
go back to reference Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, et al. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J. 2013;32:1050–4.PubMedCentralCrossRefPubMed Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, et al. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J. 2013;32:1050–4.PubMedCentralCrossRefPubMed
46.
Metadata
Title
Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markers
Authors
Maria-Cristina Arcangeletti
Rosita Vasile Simone
Isabella Rodighiero
Flora De Conto
Maria-Cristina Medici
Davide Martorana
Carlo Chezzi
Adriana Calderaro
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2015
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-015-0428-8

Other articles of this Issue 1/2015

Virology Journal 1/2015 Go to the issue